Medicamentos genéricos: uma alternativa para o mercado brasileiro

Detalhes bibliográficos
Autor(a) principal: Bermudez, Jorge
Data de Publicação: 1994
Tipo de documento: Artigo
Idioma: por
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610
Resumo: The analysis of the main characteristics of the pharmaceutical industry worldwide and market aspects of that industry in Brazil leads us to consider a high share of external dependency and oligopolization. This situation is not peculiar to our country, but is rather a global trend. Recent Government initiatives in Brazil, aiming at reducing that dependency, associated with the critical aspects regarding the prices and costs of drugs as compared to international prices, are the background that support the proposal of evaluating generic drugs as an alternative for Brazilian market. One of the most striking aspect is the verification of overpricing of raw materials as demonstrated by "transfer prices", a practice that has been observed in several countries. Analysing international concepts dealing with generic drugs, generic names and pharmaceutical equivalence, based on World Health Organization recomendations and evaluating the experiences of different countries, several actions are proposed in order to gradually enforce a policy of generic drugs, bioequivalent and interchangeable, as a possible regulatory mechanisms for Brazil.
id FIOCRUZ-5_3cc1a38464e392ce4a2fdfe110923441
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/610
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Medicamentos genéricos: uma alternativa para o mercado brasileiroMedicamentos GenéricosPolítica de Medicamentos e SaúdeIndústria FarmacêuticaBrasil: Mercado de MedicamentosThe analysis of the main characteristics of the pharmaceutical industry worldwide and market aspects of that industry in Brazil leads us to consider a high share of external dependency and oligopolization. This situation is not peculiar to our country, but is rather a global trend. Recent Government initiatives in Brazil, aiming at reducing that dependency, associated with the critical aspects regarding the prices and costs of drugs as compared to international prices, are the background that support the proposal of evaluating generic drugs as an alternative for Brazilian market. One of the most striking aspect is the verification of overpricing of raw materials as demonstrated by "transfer prices", a practice that has been observed in several countries. Analysing international concepts dealing with generic drugs, generic names and pharmaceutical equivalence, based on World Health Organization recomendations and evaluating the experiences of different countries, several actions are proposed in order to gradually enforce a policy of generic drugs, bioequivalent and interchangeable, as a possible regulatory mechanisms for Brazil.A análise das características da indústria farmacêutica no mundo e os aspectos mercadológicos desse segmento no Brasil deixam evidentes a dependência externa e a oligopolização, com predomínio de empresas de caráter mutinacional, refletindo uma tendência mundial. As iniciativas governamentais recentes no Brasil, com o objetivo de diminuir essa dependência, aliadas à gravidade da questão dos preços e custos de medicamentos no Brasil, comparados a preços mundiais, fundamentam a proposta de avaliar os medicamentos genéricos como uma alternativa viável para o mercado brasileiro. Um dos aspectos mais alarmantes é a verificação do superfaturamento de matérias-primas evidenciada pelos denominados "preços de transferência", prática constatada em diversos países. Analisando os conceitos internacionais sobre medicamentos genéricos, denominação genérica e equivalência farmacêutica, com base ainda em recomendações da Organização Mundial da Saúde e avaliando as experiências de diversos países, são propostas uma série de medidas destinadas a implementar, gradativamente, uma política de medicamentos genéricos bioequivalentes e intercambiáveis como um dos mecanismos de regulação do mercado brasileiro.Reports in Public HealthCadernos de Saúde Pública1994-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610Reports in Public Health; Vol. 10 No. 3 (1994): July/SeptemberCadernos de Saúde Pública; v. 10 n. 3 (1994): Julho/Setembro1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610/1239https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610/1240Bermudez, Jorgeinfo:eu-repo/semantics/openAccess2024-03-06T15:25:59Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/610Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:00:47.501808Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Medicamentos genéricos: uma alternativa para o mercado brasileiro
title Medicamentos genéricos: uma alternativa para o mercado brasileiro
spellingShingle Medicamentos genéricos: uma alternativa para o mercado brasileiro
Bermudez, Jorge
Medicamentos Genéricos
Política de Medicamentos e Saúde
Indústria Farmacêutica
Brasil: Mercado de Medicamentos
title_short Medicamentos genéricos: uma alternativa para o mercado brasileiro
title_full Medicamentos genéricos: uma alternativa para o mercado brasileiro
title_fullStr Medicamentos genéricos: uma alternativa para o mercado brasileiro
title_full_unstemmed Medicamentos genéricos: uma alternativa para o mercado brasileiro
title_sort Medicamentos genéricos: uma alternativa para o mercado brasileiro
author Bermudez, Jorge
author_facet Bermudez, Jorge
author_role author
dc.contributor.author.fl_str_mv Bermudez, Jorge
dc.subject.por.fl_str_mv Medicamentos Genéricos
Política de Medicamentos e Saúde
Indústria Farmacêutica
Brasil: Mercado de Medicamentos
topic Medicamentos Genéricos
Política de Medicamentos e Saúde
Indústria Farmacêutica
Brasil: Mercado de Medicamentos
description The analysis of the main characteristics of the pharmaceutical industry worldwide and market aspects of that industry in Brazil leads us to consider a high share of external dependency and oligopolization. This situation is not peculiar to our country, but is rather a global trend. Recent Government initiatives in Brazil, aiming at reducing that dependency, associated with the critical aspects regarding the prices and costs of drugs as compared to international prices, are the background that support the proposal of evaluating generic drugs as an alternative for Brazilian market. One of the most striking aspect is the verification of overpricing of raw materials as demonstrated by "transfer prices", a practice that has been observed in several countries. Analysing international concepts dealing with generic drugs, generic names and pharmaceutical equivalence, based on World Health Organization recomendations and evaluating the experiences of different countries, several actions are proposed in order to gradually enforce a policy of generic drugs, bioequivalent and interchangeable, as a possible regulatory mechanisms for Brazil.
publishDate 1994
dc.date.none.fl_str_mv 1994-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610/1239
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/610/1240
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 10 No. 3 (1994): July/September
Cadernos de Saúde Pública; v. 10 n. 3 (1994): Julho/Setembro
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943342790180865

Registros relacionados